Fig. 6From: Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinomaPDTO models are sensitive to belinostat. A PDTO (O, XO and reference) response to olaparib and (B) their morphology, C = control, scale bar: 200 µm. C PDTO (O, XO and reference) response to belinostat and (D) their morphology, C = control, scale bar: 200 µmBack to article page